In lung adenocarcinoma, low expression of the cell surface extracellular nucleotidase CD39 is related to immune infiltration and a poor prognosis.

Shao, Lili; Wang, Xiaoli; Yu, Qiongzhu; Gong, Jun; Zhang, Xiaodong; Zhou, Yan

Shao, Lili; Wang, Xiaoli; Yu, Qiongzhu; Gong, Jun; Zhang, Xiaodong; Zhou, Yan.

Afiliação

Shao L; Department of Oncology, Tumor Hospital Affiliated to Nantong University & Nantong Tumor Hospital, Nantong, China.
Wang X; Department of Oncology, Tumor Hospital Affiliated to Nantong University & Nantong Tumor Hospital, Nantong, China.
Yu Q; Department of Pathology, The Affiliated Changshu Hospital of Xuzhou Medical University, Suzhou, China.
Gong J; Department of Oncology, Tumor Hospital Affiliated to Nantong University & Nantong Tumor Hospital, Nantong, China.
Zhang X; Department of Oncology, Tumor Hospital Affiliated to Nantong University & Nantong Tumor Hospital, Nantong, China.
Zhou Y; Department of Oncology, Tumor Hospital Affiliated to Nantong University & Nantong Tumor Hospital, Nantong, China.

J Thorac Dis ; 14(12): 4938-4950, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36647506

Palavras-chave

CD39; Lung adenocarcinoma; bioinformatics analysis; immune checkpoint therapy; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Thorac Dis Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google